Newly-launched obesity company Kailera Therapeutics has announced the appointment of Jamie Coleman as chief commercial ...

Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Exxon Mobil ...

Billionaire investor Ray Dalio says dollar bulls should worry about crypto.

Anti-obesity drug Mounjaro is set to rack up global sales worth nearly £22bn a year by the end of the decade. But Donald ...

Popular Eli Lilly (LLY) weight-loss drug Zepbound ... between states and the federal government to offset the cost of the drugs. Zepbound was approved to treat sleep apnea after clinical trials ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for ... [+] health insurers, employers and government health programs who cover it in 2025.

SAN FRANCISCO — When Eli Lilly last year started offering lower-priced vials of its blockbuster obesity drug Zepbound ... d like to lower the entry cost and we’d like to have more doses ...

Popular Eli Lilly weight-loss drug Zepbound can be covered by Medicare plans to treat sleep apnea after it received Food and ...

FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly ...

What is the cost of Zepbound? While Eli Lilly doesn’t offer specific pricing information for Zepbound, it has a savings program. With eligible health insurance, you may pay as little as $25 for ...